Change - Announcement of Cessation::Resignation of Chief Executive Officer

Issuer & Securities

Issuer/ Manager
ASIAMEDIC LIMITED
Securities
ASIAMEDIC LIMITED - SG0505000059 - 505
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
15-Jan-2015 17:36:10
Status
New
Announcement Sub Title
Resignation of Chief Executive Officer
Announcement Reference
SG150115OTHROG63
Submitted By (Co./ Ind. Name)
Stanley Woo
Designation
Group Financial Controller
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and reviewed by the Company's sponsor, Xandar Capital Pte Ltd (the "Sponsor"), for compliance with the Listing Manual (Section B: Rules of Catalist) of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the information disclosed or the correctness of any of the statements made, opinions expressed or reports contained in this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST and the Sponsor assume no responsibility for the contents of this announcement including the correctness of any of the statements made, opinions expressed or reports contained in this announcement.

Contact person for the Sponsor: Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd)
Address: 22 Cross Street, #03-54/61 China Square Central, Singapore 048421
Telephone number: (65) 6319 4954

Additional Details

Name Of Person
Dr Wong Weng Hong
Age
51
Is effective date of cessation known?
Yes
If yes, please provide the date
31/01/2015
Detailed Reason (s) for cessation
To pursue personal and professional interests.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/03/2012
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer
Role and responsibilities
Role of Chief Executive Officer reporting to the Board of Directors. Responsible for carrying out the strategies and policies as established by the Board and for the overall management, development and financial performance of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No

Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
No. of ordinary voting shares in AsiaMedic Limited:
Direct interest: 62,000
Deemed interest: 14,604,000
Total: 14,666,000
Past (for the last 5 years)
Please refer to the attachment.
Present
Please refer to the attachment.

Attachments

Attachment_WWH_Directorships.pdf
Total size =4K